ReviewJournal of personalized medicine2022
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.
Alana Aragón-Herrera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ReviewJournal of personalized medicine2022
Alana Aragón-Herrera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.